Showing items 1 - 6 of 6

Epidemiology of Group A Streptococcal bacteraemia in Hunter New England Local Health District, 2008 to 2019

- Williamson, Kirsten M., Varadhan, Hemalatha, Wilson, Paul, Housen, Tambri, Merritt, Tony, Durrheim, David N., Taylor, Kylie, Crooks, Kristy, Brett, Katie, Law, Charlee, Butler, Michelle, Butler, Trent, Green, Emily, Davis, Joshua S.

Cefazolin susceptibility of coagulase-negative staphylococci (CoNS) causing late-onset neonatal bacteraemia

- Marr, I., Swe, K., Henderson, A., Lacey, J.A., Carter, G.P., Ferguson, J. K.

Duration of therapy recommended for bacteraemic illness varies widely amongst clinicians

- Alwan, Mostafa, Davis, Joshua S., Daneman, Nick, Fowler, Robert, Shehabi, Yahya, Rogers, Benjamin

Risk factors for relapse or persistence of bacteraemia caused by Enterobacter spp.: a case-control study

- Harris, Patrick N. A., Peri, Anna M., Pelecanos, Anita M., Hughes, Carly M., Paterson, David L., Ferguson, John K.

Changes in the clinical and epidemiological features of group A streptococcal bacteraemia in Australia's Northern Territory

- Gear, R. J., Carter, J. C., Carapetis, J. R., Baird, R., Davis, J. S.

Improving catheter-related blood stream infection in haemodialysis patients using a practice development framework

- Chu, Ginger, Adams, Kelly, Crawford, Sarah

  • 1
  • Disclaimer
  • Privacy
  • Copyright
  • Contact
  • Deposit